Amneal to Build Two New State-of-the-Art Manufacturing Facilities in Ahmedabad, Expanding its Longstanding Presence and Innovation Capabilities in India
Latest investment to support the development and supply of next-generation of branded medicines for obesity and metabolic diseases, including GLP-1 and amylin receptor agonists Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the Company”), a global ....